| A comprehensive PDX gastric cancer collection captures cancer cell–intrinsic transcriptional MSI traits S Corso, C Isella, SE Bellomo, M Apicella, S Durando, C Migliore, ... Cancer research 79 (22), 5884-5896, 2019 | 73 | 2019 |
| A long term, non-tumorigenic rat hepatocyte cell line and its malignant counterpart, as tools to study hepatocarcinogenesis MM Angioni, K Bellofatto, S Merlin, S Menegon, A Perra, A Petrelli, ... Oncotarget 8 (9), 15716, 2017 | 6 | 2017 |
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family C Ponzetto, A Bardelli, Z Zhen, F Maina, P dalla Zonca, S Giordano, ... Cell 77 (2), 261-271, 1994 | 1225 | 1994 |
| A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic … S Anastasi, S Giordano, O Sthandier, G Gambarotta, R Maione, ... The Journal of cell biology 137 (5), 1057-1068, 1997 | 216 | 1997 |
| A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine C Sebastian, C Ferrer, M Serra, JE Choi, N Ducano, A Mira, MS Shah, ... Nature Communications 13 (1), 1503, 2022 | 24 | 2022 |
| A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer S Khalafi, S Zhu, R Khurana, I Lohse, S Giordano, S Corso, H Al-Ali, ... Translational oncology 15 (1), 101260, 2022 | 6 | 2022 |
| A point mutation in the MET oncogene abrogates metastasis without affecting transformation S Giordano, A Bardelli, Z Zhen, S Menard, C Ponzetto, PM Comoglio Proceedings of the National Academy of Sciences 94 (25), 13868-13872, 1997 | 113 | 1997 |
| Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity A Petrelli, P Circosta, L Granziero, M Mazzone, A Pisacane, S Fenoglio, ... Proceedings of the National Academy of Sciences 103 (13), 5090-5095, 2006 | 203 | 2006 |
| Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition S Corso, E Ghiso, V Cepero, JR Sierra, C Migliore, A Bertotti, L Trusolino, ... Molecular cancer 9, 1-13, 2010 | 117 | 2010 |
| Activation of RAS family members confers resistance to ROS1 targeting drugs M Cargnelutti, S Corso, M Pergolizzi, L Mévellec, DL Aisner, ... Oncotarget 6 (7), 5182, 2015 | 87 | 2015 |
| Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013 | 697 | 2013 |
| Amplification of the MET receptor to drive resistance to anti-EGFR therapies in colorectal cancer. A Bardelli, S Corso, A Bertotti, S Hobor, G Siravegna, A Sartore-Bianchi, ... Journal of Clinical Oncology 31 (15_suppl), 11005-11005, 2013 | 3 | 2013 |
| APE1 redox function is required for activation of Yes-associated protein 1 under reflux conditions in Barrett’s-associated esophageal adenocarcinomas F Ballout, H Lu, L Chen, K Sriramajayam, J Que, Z Meng, TC Wang, ... Journal of experimental & clinical cancer research 41 (1), 264, 2022 | 10 | 2022 |
| Autocrine signaling of NRP1 ligand galectin-1 elicits resistance to BRAF-targeted therapy in melanoma cells S Rizzolio, S Corso, S Giordano, L Tamagnone Cancers 12 (8), 2218, 2020 | 11 | 2020 |
| Biomarkers of primary resistance to trastuzumab in HER2-positive metastatic gastric cancer patients: the AMNESIA case-control study F Pietrantonio, G Fucà, F Morano, A Gloghini, S Corso, G Aprile, ... Clinical Cancer Research 24 (5), 1082-1089, 2018 | 93 | 2018 |
| Biosynthesis of the protein encoded by the c-met proto-oncogene. S Giordano, MF Di Renzo, RP Narsimhan, CS Cooper, C Rosa, ... Oncogene 4 (11), 1383-1388, 1989 | 308 | 1989 |
| BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody M Sanlorenzo, I Vujic, A Floris, M Novelli, L Gammaitoni, L Giraudo, ... Clinical Cancer Research 24 (14), 3377-3385, 2018 | 33 | 2018 |
| By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy A Petrelli, R Carollo, M Cargnelutti, F Iovino, M Callari, D Cimino, ... Oncotarget 6 (4), 2315, 2015 | 50 | 2015 |
| C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells S Lin, D Rusciano, P Lorenzoni, G Hartmann, W Birchmeier, S Giordano, ... Clinical & experimental metastasis 16, 253-265, 1998 | 23 | 1998 |
| C-met is amplified but not mutated in a cell line with an activated met tyrosine kinase C Ponzetto, S Giordano, F Peverali, G Della Valle, ML Abate, G Vaula, ... Oncogene 6 (4), 553-9, 1991 | 146 | 1991 |
